局所麻酔薬市場：薬剤タイプ、種類、投与方法、流通チャネル、最終用途別-2025-2030年の世界予測

局所麻酔薬市場は、2023年に26億5,000万米ドルと評価され、2024年には28億米ドルに達すると予測され、CAGR 5.47%で成長し、2030年には38億6,000万米ドルに達すると予測されています。

局所麻酔薬は、外科手術、歯科手術、その他の医療介入中の痛みを防ぐために、身体の特定部位を麻痺させるのに重要です。これらの薬剤は神経伝導を遮断し、意識に影響を与えることなく末梢の感覚を失わせる。局所麻酔の必要性は、患者の不快感を軽減し、小手術を容易にし、外来患者の処置を向上させ、最終的にはより効率的な医療提供に貢献するという役割によって強調されています。その応用範囲は歯科、眼科、美容外科、整形外科など多岐にわたり、エンドユーザーは病院や診療所から外来手術センターや個人開業医まで多岐にわたる。

この市場を牽引しているのは、慢性疾患の増加や高齢者人口の増加による手術件数の増加であり、低リスクで効果的な疼痛管理ソリューションが必要とされています。長時間作用型局所麻酔薬の開発などの技術的進歩は、効率的かつ長時間の鎮痛に対する需要の高まりに対応する潜在的機会を提供します。さらに、全身的な副作用を軽減する局所ドラッグデリバリーシステムの開発機会も急増しており、大きな注目を集めています。

しかし、この市場は、製品承認を遅らせる可能性のある厳しい規制要件や、一部の患者における副作用やアレルギー反応のリスクによる課題に直面しており、これによって幅広い採用が制限される可能性があります。さらに、COVID-19の大流行はサプライチェーンを混乱させ、市場力学をさらに複雑にしています。生分解性麻酔薬や非注射デリバリー法などの分野での技術革新が今後の成長を牽引する可能性があります。企業は副作用の少ない薬剤の研究開発に投資し、医療機関と協力して実際の有効性をよりよく理解する必要があります。市場競争は引き続き激しく、ダイナミックであるため、持続的な成長を実現するためには、戦略的な価格設定と規制基準の遵守を徹底し、適応力を維持することが求められます。

市場力学：急速に進化する局所麻酔薬市場の主要市場インサイトを公開

局所麻酔薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の手術件数の増加に伴う、術後疼痛に対する局所麻酔薬の使用の増加
  • 局所麻酔薬の拡大および承認率の増加
• 市場抑制要因
  • 局所麻酔薬の製品回収に伴う潜在的リスク
• 市場機会
  • 効果的な局所麻酔薬のためのナノベースのドラッグデリバリーシステムの統合
  • 合成および非オピオイド局所麻酔薬の研究開発への投資
• 市場の課題
  • 局所麻酔薬の副作用

ポーターの5つの力：局所麻酔薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：局所麻酔薬市場における外部からの影響の把握

外部マクロ環境要因は、局所麻酔薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析局所麻酔薬市場における競合情勢の把握

局所麻酔薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス局所麻酔薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、局所麻酔薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨局所麻酔薬市場における成功への道筋を描く

局所麻酔薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で手術件数が増加し、術後の痛みに対する局所麻酔薬の使用が増加している
    • 局所麻酔薬の拡大と承認率の向上
  • 抑制要因
    • 局所麻酔薬の製品回収に伴う潜在的なリスク
  • 機会
    • 効果的な局所麻酔薬のためのナノベースのドラッグデリバリーシステムの統合
    • 合成および非オピオイド局所麻酔薬の研究開発への投資
  • 課題
    • 局所麻酔薬の副作用
• 市場セグメンテーション分析
  • 薬剤の種類：リドカインの有効性、即効性、適用の汎用性を向上させるための進歩
  • タイプ：中程度および高度の侵襲性手術に対する処方箋局所麻酔薬の使用
  • 投与方法：精密な用途における注射麻酔薬の新たな好感度
  • 流通チャネル：病院薬局は、病院内で局所麻酔薬への即時かつ確実なアクセスを確保するために重要な役割を果たします。
  • 最終用途：病院でのさまざまな外科手術における局所麻酔薬の広範な利用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 局所麻酔薬市場薬の種類別

• ブピバカイン
• クロロプロカイン
• リドカイン
• メピバカイン/カルボカイン
• プリロカイン
• ロピバカイン

第7章 局所麻酔薬市場：タイプ別

• 店頭
• 処方箋

第8章 局所麻酔薬市場投与方法別

• 注射可能
• 表面麻酔

第9章 局所麻酔薬市場：流通チャネル別

• ドラッグストア/薬局
• 病院薬局
• オンライン小売業

第10章 局所麻酔薬市場：最終用途別

• 外来手術センター
• 歯科医院
• 病院
• 専門クリニック

第11章 南北アメリカの局所麻酔薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の局所麻酔薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの局所麻酔薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • バクスターインターナショナル社、新たな注射剤で米国の医薬品ポートフォリオを拡大
  • ZYNRELEFの幅広い用途により、多様な外科手術における術後疼痛管理が強化されます
  • Heron TherapeuticsとCrossLink Life SciencesがZYNRELEFの流通強化に向けて戦略的提携
  • Scilex Holding Companyの主力製品 ZTlido（リドカイン局所システム）に関する新しい特許が発行されました
  • FDAがパシラのEXPARELの新規申請を承認し、非オピオイド疼痛管理の拡大を図る
  • 3Mによる歯科用局所麻酔ポートフォリオのPierrel S.p.A.への戦略的売却
  • フレゼニウスカビ、RFID対応の臭化ロクロニウム注射剤を発表
  • シンテティカSA、国内の不足の中、塩酸リドカイン注射剤の発売で米国でのプレゼンスを拡大
  • 政府とカウトロン研究所の提携による藻類ベースの局所麻酔薬製造の画期的進歩
• 戦略分析と提言
  • アスペンファーマケアホールディングスリミテッド
  • バクスターインターナショナル株式会社
  • パシラバイオサイエンス株式会社
  • テバ製薬株式会社
  • アルコン株式会社

企業一覧

• AdvaCare Pharma
• Alcon Inc.
• Anesiva, Inc.
• Aspen Pharmacare Holdings Limited
• AstraZeneca PLC
• B. Braun SE
• Baxter International, Inc.
• Boehringer Ingelheim International GmbH
• Dentsply Sirona Inc.
• Eisai Co., Ltd.
• Endo International PLC
• F. Hoffmann-La Roche Ltd.
• Fresenius SE & Co. KGaA
• Heron Therapeutics, Inc.
• Hikma Pharmaceuticals PLC
• ICPA Health Products Limited
• Mahendra Chemicals
• Merck KGaA
• Niksan Pharmaceutical
• Novartis AG
• Pacira BioSciences, Inc.
• Pfizer Inc.
• Pierrel S.p.A.
• Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd.
• Septodont Holding
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Wellona Pharma

LIST OF FIGURES

• FIGURE 1. LOCAL ANESTHESIA DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. LOCAL ANESTHESIA DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LOCAL ANESTHESIA DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LOCAL ANESTHESIA DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHLOROPROCAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE/ CARBOCAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURFACE ANESTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG STORES/PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE RETAILING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 166. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 167. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 186. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 187. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 191. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 192. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 238. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

The Local Anesthesia Drugs Market was valued at USD 2.65 billion in 2023, expected to reach USD 2.80 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 3.86 billion by 2030.

Local anesthesia drugs are crucial in numbing specific areas of the body to prevent pain during surgical procedures, dental operations, and other medical interventions. These drugs block nerve conduction, leading to a loss of sensation in peripheral areas without affecting consciousness. The necessity of local anesthesia is underscored by its role in reducing patient discomfort, facilitating minor surgeries, and enhancing outpatient procedures, ultimately contributing to more efficient healthcare delivery. Its application spans across multiple domains including dentistry, ophthalmology, cosmetic surgery, and orthopedic processes, while end-users range from hospitals and clinics to ambulatory surgical centers and individual practitioners.

The market is primarily driven by the increasing prevalence of surgeries due to rising chronic diseases and the growing elderly population, which necessitates low-risk, effective pain management solutions. Technological advancements, such as the development of long-acting local anesthetics, offer potential opportunities to cater to the growing demand for efficient and extended pain relief. Additionally, there's a burgeoning opportunity in developing localized drug delivery systems that reduce systemic side effects, thereby attracting significant attention.

However, the market faces challenges due to stringent regulatory requirements that can delay product approvals and the risk of side effects and allergic reactions in some patients, which can limit wider adoption. Moreover, the COVID-19 pandemic has disrupted supply chains, further complicating market dynamics. Innovating in areas such as biodegradable anesthetics and non-injection delivery methods may drive future growth. Companies should invest in R&D for drugs with fewer side effects and collaborate with medical institutions to better understand real-world efficacy. The market remains competitive and dynamic, requiring players to remain adaptive, ensuring strategic pricing and compliance with regulatory standards to capture sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Local Anesthesia Drugs Market

The Local Anesthesia Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing use of local anesthetic for post-operative pain with rising surgeries across the globe
  • Increase in expansion and approval rate of local anesthesia drugs
• Market Restraints
  • Potential risk associated with the product recall of local anesthetic drugs
• Market Opportunities
  • Integration of nano-based drug delivery systems for effective local anesthetics
  • Investment in R&D for synthetic and non-opioid local anesthetics
• Market Challenges
  • Side effects of local anesthetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Local Anesthesia Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Local Anesthesia Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Local Anesthesia Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Local Anesthesia Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Local Anesthesia Drugs Market

A detailed market share analysis in the Local Anesthesia Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Local Anesthesia Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Local Anesthesia Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Local Anesthesia Drugs Market

A strategic analysis of the Local Anesthesia Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Local Anesthesia Drugs Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Alcon Inc., Anesiva, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun SE, Baxter International, Inc., Boehringer Ingelheim International GmbH, Dentsply Sirona Inc., Eisai Co., Ltd., Endo International PLC, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Heron Therapeutics, Inc., Hikma Pharmaceuticals PLC, ICPA Health Products Limited, Mahendra Chemicals, Merck KGaA, Niksan Pharmaceutical, Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Pierrel S.p.A., Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd., Septodont Holding, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Wellona Pharma.

Market Segmentation & Coverage

This research report categorizes the Local Anesthesia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Bupivacaine, Chloroprocaine, Lidocaine, Mepivacaine/ Carbocaine, Prilocaine, and Ropivacaine.
• Based on Type, market is studied across Over-the-Counter and Prescription.
• Based on Mode of Administration, market is studied across Injectable and Surface Anesthetic.
• Based on Distribution Channel, market is studied across Drug Stores/Pharmacies, Hospitals Pharmacies, and Online Retailing.
• Based on End-Use, market is studied across Ambulatory Surgical Centers, Dental Clinics, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing use of local anesthetic for post-operative pain with rising surgeries across the globe
    • 5.1.1.2. Increase in expansion and approval rate of local anesthesia drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Potential risk associated with the product recall of local anesthetic drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of nano-based drug delivery systems for effective local anesthetics
    • 5.1.3.2. Investment in R&D for synthetic and non-opioid local anesthetics
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects of local anesthetic drugs
• 5.2. Market Segmentation Analysis
  • 5.2.1. Drug Type: Advancements to improve the effectiveness, rapid onset, and versatility in the application of lidocaine
  • 5.2.2. Type: Usage of prescription local anesthesia drugs for moderately and highly invasive surgeries
  • 5.2.3. Mode of Administration: Emerging preference for injectable anesthetics in precise applications
  • 5.2.4. Distribution Channel: Critical role played by hospital pharmacies for ensuring immediate and reliable access to local anesthesia drugs in hospital settings
  • 5.2.5. End-Use: Extensive utilization of local anesthesia drugs in hospital settings for diverse surgical operations
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Local Anesthesia Drugs Market, by Drug Type

• 6.1. Introduction
• 6.2. Bupivacaine
• 6.3. Chloroprocaine
• 6.4. Lidocaine
• 6.5. Mepivacaine/ Carbocaine
• 6.6. Prilocaine
• 6.7. Ropivacaine

7. Local Anesthesia Drugs Market, by Type

• 7.1. Introduction
• 7.2. Over-the-Counter
• 7.3. Prescription

8. Local Anesthesia Drugs Market, by Mode of Administration

• 8.1. Introduction
• 8.2. Injectable
• 8.3. Surface Anesthetic

9. Local Anesthesia Drugs Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Drug Stores/Pharmacies
• 9.3. Hospitals Pharmacies
• 9.4. Online Retailing

10. Local Anesthesia Drugs Market, by End-Use

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Dental Clinics
• 10.4. Hospitals
• 10.5. Specialty Clinics

11. Americas Local Anesthesia Drugs Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Local Anesthesia Drugs Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Local Anesthesia Drugs Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Baxter International Inc. Expands the U.S. Pharmaceuticals Portfolio with New Injectable Products
  • 14.3.2. Broadened Applications of ZYNRELEF Enhance Postoperative Pain Management in Diverse Surgical Procedures
  • 14.3.3. Strategic Alliance between Heron Therapeutics and CrossLink Life Sciences to Enhance Distribution of ZYNRELEF
  • 14.3.4. New Patent Issuence for Scilex Holding Company for Its Lead Commercial Product ZTlido (lidocaine topical system)
  • 14.3.5. FDA Approves New Applications for Pacira's EXPAREL Expanding Non-Opioid Pain Management
  • 14.3.6. Strategic Divestiture of Dental Local Anesthetic Portfolio by 3M to Pierrel S.p.A.
  • 14.3.7. Fresenius Kabi Introduces RFID-Enabled Rocuronium Bromide Injection
  • 14.3.8. Sintetica S.A. Expands U.S. Presence with Launch of Lidocaine Hydrochloride Injection Amid National Shortage
  • 14.3.9. Breakthrough in Algae-Based Local Anaesthetic Production through Government-Cawthron Institute Partnership
• 14.4. Strategy Analysis & Recommendation
  • 14.4.1. Aspen Pharmacare Holdings Limited
  • 14.4.2. Baxter International, Inc.
  • 14.4.3. Pacira BioSciences, Inc.
  • 14.4.4. Teva Pharmaceutical Industries Ltd.
  • 14.4.5. Alcon Inc.

Companies Mentioned

• 1. AdvaCare Pharma
• 2. Alcon Inc.
• 3. Anesiva, Inc.
• 4. Aspen Pharmacare Holdings Limited
• 5. AstraZeneca PLC
• 6. B. Braun SE
• 7. Baxter International, Inc.
• 8. Boehringer Ingelheim International GmbH
• 9. Dentsply Sirona Inc.
• 10. Eisai Co., Ltd.
• 11. Endo International PLC
• 12. F. Hoffmann-La Roche Ltd.
• 13. Fresenius SE & Co. KGaA
• 14. Heron Therapeutics, Inc.
• 15. Hikma Pharmaceuticals PLC
• 16. ICPA Health Products Limited
• 17. Mahendra Chemicals
• 18. Merck KGaA
• 19. Niksan Pharmaceutical
• 20. Novartis AG
• 21. Pacira BioSciences, Inc.
• 22. Pfizer Inc.
• 23. Pierrel S.p.A.
• 24. Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd.
• 25. Septodont Holding
• 26. Teva Pharmaceutical Industries Ltd.
• 27. Viatris Inc.
• 28. Wellona Pharma